ECOR electroCore, Inc.

NASDAQ
$7.25

electroCore, Inc. (ECOR) is expected to report earnings on February 3, 2027, after the market close. The consensus earnings estimate is a loss of $0.14 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -10.7% since its last earnings release on November 4, 2026.

electroCore Beat Consensus Estimates, Lowers Guidance
Wednesday, November 4, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 3
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.14)
Rev est $11.89M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $8.16

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Charts powered in part by Lightweight Charts™ by TradingView.